Guardant Health, Inc. entered into an underwriting agreement to issue and sell 12,500,000 shares of its common stock to underwriters, with an option for the underwriters to purchase additional shares. The offering closed, resulting in the sale of 14,375,000 shares and net proceeds of approximately $380.5 million.